Journey Medical Corp (DERM)

Import this data to Google Sheets with:

=jivedata("DERM","financials")

Full statements spill as a table. For one cell: =jivedata("DERM","Revenue") or =jivedata("DERM","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

Journey Medical Corp

DERM • CIK 0001867066

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Revenue from Contract with Customer, Excluding Assessed Tax	$59,662	$55,134	$61,239	$66,851
Other Income	$19,519	$1,000	$619	$619
Revenues	$79,181	$56,134	$61,858	$68,181
Operating Income (Loss)	$-2,073	$-13,677	$-8,172	$-3,008
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$-3,632	$-14,611	$-11,371	$-6,089
Income Tax Expense (Benefit)	$221	$61	$60	$15
Net Income (Loss) Attributable to Parent	$-3,853	$-14,672	$-11,431	$-6,104
Cost of Revenue	$26,660	$20,879	$20,924	$23,556
Amortization of Intangible Assets	$3,767	$3,424	$4,258	$4,224
Research and Development Expense	$7,541	$9,857	$480	$495
Selling, General and Administrative Expense	$43,910	$40,204	$44,368	$42,914
Costs and Expenses	$81,254	$69,811	$70,030	$71,189
InterestExpenseNonoperating	—	$2,700	$3,698	$3,668
Gain (Loss) on Extinguishment of Debt	—	$1,125	$1,125	$1,125
Foreign Currency Transaction Gain (Loss), before Tax	$-183	$-116	$-90	$-26
Nonoperating Income (Expense)	$-1,559	$-934	$-3,199	$-3,081
Weighted Average Number of Shares Outstanding, Basic	18,232,422	20,431,400	24,497,973	28,945,053
Weighted Average Number of Shares Outstanding, Diluted	—	20,431,400	24,497,973	28,945,053

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Intangible Assets, Net (Excluding Goodwill)	$20,287	$31,863	$27,605	$25,510
Operating Lease, Right-of-Use Asset	$101	$199	$111	$65
Assets	$76,849	$80,241	$94,589	$98,356
Cash and Cash Equivalents, at Carrying Value	$27,439	$20,305	$24,090	$25,643
Accounts Receivable, after Allowance for Credit Loss, Current	$15,222	$10,231	$29,783	$36,246
Inventory, Net	$10,206	$14,431	$9,624	$8,156
Prepaid Expense and Other Assets, Current	$3,588	$3,212	$3,376	$2,736
Assets, Current	$56,455	$48,179	$66,873	$72,781
Long-term Debt, Excluding Current Maturities	$14,622	$24,879	$25,277	$20,472
Operating Lease, Liability, Noncurrent	$9	$118	$18	$18
Liabilities	$56,499	$60,172	$62,737	$66,242
Additional Paid in Capital	$92,703	$107,094	$130,307	$133,111
Retained Earnings (Accumulated Deficit)	$-72,355	$-87,027	$-98,458	$-101,000
Stockholders' Equity Attributable to Parent	$20,350	$20,069	$31,852	$32,114
Accounts Payable, Current	$18,149	$16,050	$8,851	$8,049
Other Liabilities, Current	$195	$528	$455	$405
Accrued Liabilities, Current	$20,350	$17,425	$27,567	$31,831
Interest Payable, Current	$22	$404	$398	$416
Accrued Income Taxes, Current	$53	$60	$70	$70
Operating Lease, Liability, Current	$99	$83	$101	$69
Liabilities, Current	$41,868	$35,175	$37,442	$45,770
Common Stock, Shares Authorized	50,000,000	50,000,000	50,000,000	50,000,000

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$-3,853	$-14,672	$-11,431	$-6,104
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$-4,564	$-7,134	$3,785	$5,350
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$27,439	$20,305	$24,090	$30,239
Accounts Receivable, Credit Loss Expense (Reversal)	$435	$516	$-211	$54
Payments to Acquire Productive Assets	$5,000	$15,000	$15,000	$15,000
Gain (Loss) on Extinguishment of Debt	—	$1,125	$1,125	$1,125
Net Cash Provided by (Used in) Investing Activities	$-5,000	$-15,000	$-15,000	$-15,000
Amortization of Debt Discount (Premium)	$356	$307	$466	$436
Amortization of Intangible Assets	$3,767	$3,424	$4,258	$4,224
Operating Lease, Right-of-Use Asset, Amortization Expense	$88	$91	$88	$91
Share-based Payment Arrangement, Noncash Expense	$2,606	$6,098	$6,288	$6,055
Proceeds from Stock Options Exercised	$121	$207	$350	$340
Proceeds from Issuance of Common Stock	—	$7,877	$16,359	$16,359
Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised	—	$209	$217	$266
Proceeds from Long-term Lines of Credit	$15,000	$10,000	$10,000	$10,000
Payments of Financing Costs	—	$50	$75	$75
Repayments of Notes Payable	$1,000	$1,250	$625	$625
Net Cash Provided by (Used in) Financing Activities	$-4,804	$16,993	$16,226	$12,842
Interest Paid, Excluding Capitalized Interest, Operating Activities	$1,127	$2,011	$3,238	$3,232
Income Taxes Paid, Net	$181	$125	$50	$86
Increase (Decrease) in Accounts Receivable	$-12,551	$-4,475	$19,341	$20,656
Increase (Decrease) in Inventories	$-3,953	$4,225	$-4,807	$-4,696
Increase (Decrease) in Prepaid Expense and Other Assets	$279	$-376	$164	$257
Increase (Decrease) in Other Operating Assets	$-55	$-6	$-6	$-6
Increase (Decrease) in Accounts Payable	$-18,421	$-2,099	$-7,199	$-4,705
Increase (Decrease) in Accrued Liabilities	$962	$-2,925	$10,149	$9,276
Increase (Decrease) in Interest Payable, Net	$-138	$382	$-6	$0
Increase (Decrease) in Income Taxes Payable	$18	$7	$10	$-71
IncreaseDecreaseInOperatingLeaseLiability	$-83	$-96	$-82	$-96
Net Cash Provided by (Used in) Operating Activities	$5,240	$-9,127	$-12,441	$-7,492

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("DERM","financials")

Full statements spill as a table. For one cell: =jivedata("DERM","Revenue") or =jivedata("DERM","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.